The enrichment pathways identified following KEGG analysis that contained the most core targets included proteoglycans in cancer, prostate cancer, endocrine resistance, the PI3K-Akt signaling pathway, and more (Figure S8B). This evidence concerns the gene AKT1 and prostate carcinoma.